Welcome to SENHWA BIOSCIENCES, INC. Senhwa Biosciences Senhwa is a new drug development company registered in the Taiwan with operations in Taiwan and USA.
OVERVIEW
SENHWABIOSCIENCES.COM TRAFFIC
Date Range
Date Range
Date Range
SENHWABIOSCIENCES.COM HISTORY
SITE AGE
LINKS TO DOMAIN
The Sanderling team brings together a diverse group of individuals, each distinguished by their solid operating experience that they bring to bear in working with entrepreneurs. Since its inception, Sanderling has supported more than 90 biomedical companies earning consistently high rates of return and building a superior track record of success. Magnetic Device Achieves Persistent Control of GERD at Five Years. New Study Demonstrates LINX Safety and Efficacy.
WI Harper Group is a global leader in cross-border investing between the United States and Greater China. Founded in 1996 by Chinese venture capital pioneer Peter Liu, the firm has built a fully integrated platform dedicated to investing in the U. S and the Greater China market. WI Harper is a pioneer and helped shape the development of the venture capital ecosystem in Asia.
WHAT DOES SENHWABIOSCIENCES.COM LOOK LIKE?
CONTACTS
edirect corp.
mailer my
13F., No.102, Guangfu S. Rd., Da-an District
Taipei, Taiwan, 106
TW
SENHWABIOSCIENCES.COM SERVER
NAME SERVERS
SERVER OS
We discovered that this website is operating the Apache os.HTML TITLE
Welcome to SENHWA BIOSCIENCES, INC. Senhwa Biosciences Senhwa is a new drug development company registered in the Taiwan with operations in Taiwan and USA.DESCRIPTION
Language English Traditional Chinese. Senhwa Biosciences identifies and develops innovative therapies that will fundamentally change the way patients are treated. Senhwa is developing small molecule oncology drugs targeting Pol I and CK2. Senhwa Biosciences Receives Permission for Korean Phase 12 Trial of CX-4945 in Combination with Gemcitabine and Cisplatin. Inhibitor of RNA Polymerase I Shows Promise as Potential Treatment for Acute Myeloid Leukemia and Multiple Myeloma.PARSED CONTENT
The site senhwabiosciences.com had the following in the web page, "Senhwa Biosciences identifies and develops innovative therapies that will fundamentally change the way patients are treated." We observed that the website stated " Senhwa is developing small molecule oncology drugs targeting Pol I and CK2." It also stated " Senhwa Biosciences Receives Permission for Korean Phase 12 Trial of CX-4945 in Combination with Gemcitabine and Cisplatin. Inhibitor of RNA Polymerase I Shows Promise as Potential Treatment for Acute Myeloid Leukemia and Multiple Myeloma."SEEK MORE WEBSITES
Forgot Password or Username? Deviant for 4 Years. This is the place where you can personalize your profile! By moving, adding and personalizing widgets.
Blog ini hanya sesuai untuk mereka yang telah berkahwin dan akan mendirikan rumah tangga sahaja. Berkongsi memberi sedikit ilmu rumah tangga untuk membantu mereka yang mempunyai masalah perkahwinan mereka di dalam perhubungan intim seharian. Semoga blog ini dapat mengeratkan lagi hubungan harmonis suami isteri. 73 peratus wanita tak puas di ranjang. Apakah yang dicari oleh Lelaki pada seorang Wanita.
Mendedahkan taekwando zaman beliau dengan sekarang. Apa bezanya? Kenapa tajuk Azlan Ghanie sebegitu bulan ini? Apa yang dibengang dan kenapa bangang. Seorang warga silat dengan nama pena Wasit Pencen. Seorang tokoh beladiri, Dr Song Swee Hee.
Blinkies fait dans les 48h. Converted to Blogger by Girly Blogger.